A patient contact reported to fresenius that a peritoneal dialysis (pd) patient on continuous cyclic pd {ccpd) therapy on the liberty select cycler expired.There was no specific allegation this event was related to a deficiency or malfunction of any fresenius device(s) or product(s) in the initial reporting.Upon follow up, the patient's pd registered nurse reported this patient was hospitalized on (b)(6) 2021 for sepsis with resulting cardiac complications.It was reported the patient had significant cardiac disease {exact diagnoses unknown) prior to this event that required a coronary arterial bypass graft and stent placement.It was stated the source of the patient's sepsis was more than likely attributed to an outpatient procedure for a pd catheter (not a fresenius product) replacement on (b)(6) 2021 due to a refractory tunnel infection.It was confirmed the patient's sepsis were unrelated to pd therapy and not due to a deficiency or malfunction of any fresenius product(s) or device(s).(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|